| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 31, 2025 | Disposed to issuer(D) | 543 | — | $0 | 160 |
| Mar 31, 2025 | Disposed to issuer(D) | 460 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 2K | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 9K | — | $0 | 3K |
| Mar 31, 2025 | Disposed to issuer(D) | 331 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 262 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 350 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 381 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 496 | — | $0 | 0 |
| Mar 31, 2025 | Disposed to issuer(D) | 154 | — | $0 | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-001058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Atara Biotherapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0000905148-25-001058"
Use Arkolith to summarize insider buying and selling at Atara Biotherapeutics, Inc. over the last 90 days and cite the filings.